Teligent expects audit at injectables site

Teligent’s president and chief executive officer Jason Grenfell-Gardner says the firm anticipates a pre-approval inspection (PAI) by the US Food and Drug Administration (FDA) at its recently-expanded US manufacturing facility in Buena, New Jersey, in early 2019.